288 related articles for article (PubMed ID: 31467935)
1. Promiscuous Chemokine Antagonist (BKT130) Suppresses Laser-Induced Choroidal Neovascularization by Inhibition of Monocyte Recruitment.
Hagbi-Levi S; Abraham M; Tiosano L; Rinsky B; Grunin M; Eizenberg O; Peled A; Chowers I
J Immunol Res; 2019; 2019():8535273. PubMed ID: 31467935
[TBL] [Abstract][Full Text] [Related]
2. VEGF-production by CCR2-dependent macrophages contributes to laser-induced choroidal neovascularization.
Krause TA; Alex AF; Engel DR; Kurts C; Eter N
PLoS One; 2014; 9(4):e94313. PubMed ID: 24714223
[TBL] [Abstract][Full Text] [Related]
3. Intravitreal TSG-6 suppresses laser-induced choroidal neovascularization by inhibiting CCR2+ monocyte recruitment.
Kim SJ; Lee HJ; Yun JH; Ko JH; Choi DY; Oh JY
Sci Rep; 2015 Jul; 5():11872. PubMed ID: 26149224
[TBL] [Abstract][Full Text] [Related]
4. Co-inhibition of PGF and VEGF blocks their expression in mononuclear phagocytes and limits neovascularization and leakage in the murine retina.
Balser C; Wolf A; Herb M; Langmann T
J Neuroinflammation; 2019 Feb; 16(1):26. PubMed ID: 30732627
[TBL] [Abstract][Full Text] [Related]
5. Suppression and regression of choroidal neovascularization in mice by a novel CCR2 antagonist, INCB3344.
Xie P; Kamei M; Suzuki M; Matsumura N; Nishida K; Sakimoto S; Sakaguchi H; Nishida K
PLoS One; 2011; 6(12):e28933. PubMed ID: 22205983
[TBL] [Abstract][Full Text] [Related]
6. Serine racemase deficiency attenuates choroidal neovascularization and reduces nitric oxide and VEGF levels by retinal pigment epithelial cells.
Jiang H; Wu M; Liu Y; Song L; Li S; Wang X; Zhang YF; Fang J; Wu S
J Neurochem; 2017 Nov; 143(3):375-388. PubMed ID: 28892569
[TBL] [Abstract][Full Text] [Related]
7. Retinal Inhibition of CCR3 Induces Retinal Cell Death in a Murine Model of Choroidal Neovascularization.
Wang H; Han X; Gambhir D; Becker S; Kunz E; Liu AJ; Hartnett ME
PLoS One; 2016; 11(6):e0157748. PubMed ID: 27309355
[TBL] [Abstract][Full Text] [Related]
8. Monocyte-Derived Macrophages Are Necessary for Beta-Adrenergic Receptor-Driven Choroidal Neovascularization Inhibition.
Droho S; Cuda CM; Perlman H; Lavine JA
Invest Ophthalmol Vis Sci; 2019 Dec; 60(15):5059-5069. PubMed ID: 31800964
[TBL] [Abstract][Full Text] [Related]
9. Preclinical Efficacy and Safety of VEGF-Grab, a Novel Anti-VEGF Drug, and Its Comparison to Aflibercept.
Hong HK; Park YJ; Kim DK; Ryoo NK; Ko YJ; Park KH; Kim HM; Woo SJ
Invest Ophthalmol Vis Sci; 2020 Nov; 61(13):22. PubMed ID: 33196778
[TBL] [Abstract][Full Text] [Related]
10. Blockade of vascular adhesion protein-1 attenuates choroidal neovascularization.
Yoshikawa N; Noda K; Ozawa Y; Tsubota K; Mashima Y; Ishida S
Mol Vis; 2012; 18():593-600. PubMed ID: 22419852
[TBL] [Abstract][Full Text] [Related]
11. VEGF receptor blockade markedly reduces retinal microglia/macrophage infiltration into laser-induced CNV.
Huang H; Parlier R; Shen JK; Lutty GA; Vinores SA
PLoS One; 2013; 8(8):e71808. PubMed ID: 23977149
[TBL] [Abstract][Full Text] [Related]
12. The short-term effects of aflibercept on the size of choroidal neovascularization lesion in treatment-resistant neovascular age-related macular degeneration as determined by spectral-domain optical coherence tomography.
Abri Aghdam K; Seidensticker F; Pielen A; Framme C; Junker B
Lasers Surg Med; 2016 Sep; 48(7):668-77. PubMed ID: 27111455
[TBL] [Abstract][Full Text] [Related]
13. A Novel Platelet-Activating Factor Receptor Antagonist Inhibits Choroidal Neovascularization and Subretinal Fibrosis.
Zhang H; Yang Y; Takeda A; Yoshimura T; Oshima Y; Sonoda KH; Ishibashi T
PLoS One; 2013; 8(6):e68173. PubMed ID: 23826375
[TBL] [Abstract][Full Text] [Related]
14. Blockage of PI3K/mTOR Pathways Inhibits Laser-Induced Choroidal Neovascularization and Improves Outcomes Relative to VEGF-A Suppression Alone.
Ma J; Sun Y; López FJ; Adamson P; Kurali E; Lashkari K
Invest Ophthalmol Vis Sci; 2016 Jun; 57(7):3138-44. PubMed ID: 27304845
[TBL] [Abstract][Full Text] [Related]
15. Monocyte/macrophages promote vasculogenesis in choroidal neovascularization in mice by stimulating SDF-1 expression in RPE cells.
Shi YY; Wang YS; Zhang ZX; Cai Y; Zhou J; Hou HY; van Rooijen N
Graefes Arch Clin Exp Ophthalmol; 2011 Nov; 249(11):1667-79. PubMed ID: 21655971
[TBL] [Abstract][Full Text] [Related]
16. Repurposing bortezomib for choroidal neovascularization treatment via antagonizing VEGF-A and PDGF-D mediated signaling.
Liu Y; Feng M; Cai J; Li S; Dai X; Shan G; Wu S
Exp Eye Res; 2021 Mar; 204():108446. PubMed ID: 33476605
[TBL] [Abstract][Full Text] [Related]
17. Myeloid cells expressing VEGF and arginase-1 following uptake of damaged retinal pigment epithelium suggests potential mechanism that drives the onset of choroidal angiogenesis in mice.
Liu J; Copland DA; Horie S; Wu WK; Chen M; Xu Y; Paul Morgan B; Mack M; Xu H; Nicholson LB; Dick AD
PLoS One; 2013; 8(8):e72935. PubMed ID: 23977372
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of Placenta Growth Factor Reduces Subretinal Mononuclear Phagocyte Accumulation in Choroidal Neovascularization.
Crespo-Garcia S; Corkhill C; Roubeix C; Davids AM; Kociok N; Strauss O; Joussen AM; Reichhart N
Invest Ophthalmol Vis Sci; 2017 Oct; 58(12):4997-5006. PubMed ID: 28979997
[TBL] [Abstract][Full Text] [Related]
19. Therapeutic Effects of PPARα Agonist on Ocular Neovascularization in Models Recapitulating Neovascular Age-Related Macular Degeneration.
Qiu F; Matlock G; Chen Q; Zhou K; Du Y; Wang X; Ma JX
Invest Ophthalmol Vis Sci; 2017 Oct; 58(12):5065-5075. PubMed ID: 28980001
[TBL] [Abstract][Full Text] [Related]
20. Association of CD11b+ Monocytes and Anti-Vascular Endothelial Growth Factor Injections in Treatment of Neovascular Age-Related Macular Degeneration and Polypoidal Choroidal Vasculopathy.
Subhi Y; Krogh Nielsen M; Molbech CR; Krüger Falk M; Singh A; Hviid TVF; Nissen MH; Sørensen TL
JAMA Ophthalmol; 2019 May; 137(5):515-522. PubMed ID: 30844038
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
